# Feasibility and Acceptability of a Smartphone App to Assess Early Warning Signs of Psychosis Relapse

> **NCT03558529** · — · COMPLETED · sponsor: **Manchester Academic Health Science Centre** · enrollment: 27 (actual)

## Conditions studied

- Schizophrenia Relapse
- Schizophrenia
- Schizo Affective Disorder
- Psychotic Disorders
- Psychosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03558529
- **Lead sponsor:** Manchester Academic Health Science Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-01
- **Primary completion:** 2018-04-01
- **Final completion:** 2018-04-01
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2018-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03558529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03558529, "Feasibility and Acceptability of a Smartphone App to Assess Early Warning Signs of Psychosis Relapse". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03558529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*